The developers said that their multivariant analysis does a better job than using APOE E4 alone at identifying those at greatest risk of developing Alzheimer's.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
A pair of studies has established a potential role for specific gut bacteria in the progression of MS, suggesting therapeutic targeting of the microbiota as a potential treatment.
In PNAS this week: links between the gut microbiome and multiple sclerosis, and more.
The researchers used this approach to show how non-coding variation associated with human immune dysfunction alters context-specific gene programs.
The consortium aims to advance the use of genomics in the clinic, with a particular focus on diverse and underserved patient populations.
The $10 million donation from Mark Zuckerberg and Priscilla Chan should accelerate data sharing and alleviate shortage in bioinformatics expertise.
The gift will support work being done by Atul Butte using publicly availably health data to gain new insights on disease.
The firm recently released two droplet digital PCR-based assays that can characterize edits generated by CRISPR-Cas9 or other genome editing tools.
Focusing on drugs that appeared to reverse cancer-related gene expression signatures, researchers identified candidate compounds that thwarted cancer cell lines.
In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.
Canadian regulators are beginning to share information from new drug studies, Undark reports.
In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.
Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.